000			01658 a2200469 4500
005			20250513210416.0
264		0	_c20000728
008			200007s 0 0 eng d
022			_a0959-8049
024	7		_a10.1016/s0959-8049(00)00013-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aCameron, D A
245	0	0	_aEffective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes. _h[electronic resource]
260			_bEuropean journal of cancer (Oxford, England : 1990) _cMay 2000
300			_a845-51 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntigens, Neoplasm _xmetabolism
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Division _xdrug effects
650	0	4	_aDNA Topoisomerases, Type II
650	0	4	_aDNA-Binding Proteins
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aMitosis _xdrug effects
650	0	4	_aNuclear Proteins _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xmetabolism
650	0	4	_aTamoxifen _xtherapeutic use
650	0	4	_aTime Factors
700	1		_aKeen, J C
700	1		_aDixon, J M
700	1		_aBellamy, C
700	1		_aHanby, A
700	1		_aAnderson, T J
700	1		_aMiller, W R
773	0		_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 36 _gno. 7 _gp. 845-51
856	4	0	_uhttps://doi.org/10.1016/s0959-8049(00)00013-7 _zAvailable from publisher's website
999			_c10737934 _d10737934